Relationship of deficits of FMR1 gene specific protein with physical phenotype of fragile X males and females in pedigrees: A new perspective

American Journal of Medical Genetics

Volumn 118 A, Issue 2, 2003, Pages 127-134

  Loesch, D Z ^a   Huggins, R M ^a   Bui, Q M ^a   Taylor, A K ^b   Hageman, R J ^c  

^a LA TROBE UNIVERSITY   (Australia)

^b Kimball Genetics Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

FMR1 protein; Fragile X; Genotype phenotype relationships; Pedigree analysis; Physical measures; Robust modification

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; GENE PRODUCT; FMR1 PROTEIN, HUMAN; NERVE PROTEIN; RNA BINDING PROTEIN;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; BODY HEIGHT; CHILD; FEMALE; FRAGILE X SYNDROME; GENE MUTATION; GENOTYPE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STATISTICAL MODEL; ANTHROPOMETRY; ARTICLE; BIOLOGICAL MODEL; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; CHILD; CHILD, PRESCHOOL; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MUTATION; NERVE TISSUE PROTEINS; PHENOTYPE; RNA-BINDING PROTEINS;

EID: 0038162524     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Aptech Systems. 1994. GAUSS. Maple Valley, WA: Aptech Systems.
2. Butler MG, Brunschwig A, Miller LK, Hagerman RJ. 1992. Standards for selected anthropometric measurements in males with the fragile X syndrome. Pediatrics 89:1059-1062.
3. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weler IJ, Greenough WT. 1997. Abnormal dendritic spines in fragile X knockout mouse: Maturation and pruning deficits. Proc Natl Acad Sci 94:5401-5404.
4. Corbin F, Bouillon M, Fortin A, Morin S, Rousseau F, Khandjin EW. 1997. The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. Hum Mol Genet 6:1465-1472.
5. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. 1993. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4(4):335-340.
6. Hagerman RJ. 2002. Physical and behavioral phenotype. In: Hagerman RJ, Hagerman PJ, editors. Fragile X syndrome: diagnosis, treatment and research, 3rd ed. Baltimore: The Johns Hopkins University Press. p 3-109.
7. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, Schalling M. 1993. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 3(1):36-43.
8. Huggins RM. 1993. On the robust analysis of pedigree data. Austral J Stat 35:43-57.
9. Kaufman WE, Abrams MT, Chen W, Reiss AL. 1999. Genotype, molecular phenotype: Correlations in fragile X syndrome. Am J Med Genet 83:286-295.
10. Lange K, Westlake J, Spence MA. 1976. Extensions to pedigree analysis. III. Variance components by the scoring method. Ann Hum Genet 50:385-398.
11. Loesch DZ, Huggins RM. 1992. Fixed and random effects in the variation of the finger ridge count: A study of fragile X families. Am J Hum Genet 50:1067-1076.
12. Loesch DZ, Lafranchi M, Scott D. 1988. Anthropometry in Martin-Bell Syndrome. Am J Med Genet 30:149-164.
13. Loesch DZ, Huggins RM, Hoang NH. 1995. Growth in stature in fragile X families: A mixed longitudinal study. Am J Med Genet 58:249-256.
14. Loesch DZ, Huggins RM, Stokes KM. 1999. Relationship of birth weight and length with growth in height and body diameters from 5 years of age to maturity. Am J Hum Biol 11:772-778.
15. Loesch DZ, Huggins RM, Bui MQ, Epstein JL, Taylor AK, Hagerman RJ. RJ Effect of the deficits of Fragile X mental retardation protein (FMRP) on cognitive status of fragile X males and females assessed by robust pedigree analysis. J Develop Behav Pediatr (in press).
16. Loesch DZ, Huggins RM, Taylor AK. 2002. Application of robust pedigree analysis in studies of complex genotype-phenotype relationships in fragile X syndrome. Am J Med Genet 107:136-142.
17. Martin R, Saller K. 1957. Lehrbuch der Anthropologie. Vol 1: Stuttgart: Gustav Fisher Verlag. pp 308-386.
18. Meryash DL, Cronk CE, Sacks B, Gerald PS. 1984. An anthropometric study of males with the fragile X syndrome. Am J Med Genet 17:159-174.
19. Opitz JM, Westphal JM, Daniel A. 1984. Discovery of a connective tissue dysplasia in the Martin Bell syndrome. Am J Med Genet 17:101-109.
20. Partington MW. 1984. The fragile X syndrome: Preliminary data on growth and development in males. Am J Med Genet 17:175-194.
21. Pieretti M, Zhang F, Fu Y-H, Warren ST, Oostra BA, Caskey CT, Nelson DL. 1991. Absence of expression of the FMR1 gene in the fragile X syndrome. Cell 66:817-822.
22. Preece MA, Baines MJ. 1978. A new family of mathematical models describing the human growth curve. Ann Hum Biol 5:1-24.
23. Reiss A, Abrams M, Greenlaw R, Freund L, Denckla MB. 1995. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med 1:159-167.
24. Reiss AL, Freund LS, Baumgardner TL, Abrams MT, Denckla MB. 1995. Contribution of the FMR1 gene mutation to human intellectual dysfunction. Nat Genet 11:331-334.
25. Reiss AL, Eliez S, Smith JE, Patwardhan A, Haberecht M. 2000. Brain imaging in neurogenetic conditions: Realizing the potential of behavioural neurogenetics research. MRDD Res Rev 6:186-197.
26. Riddle JE, Cheema A, Sobesky WE, Gardner SC, Taylor AK, Pennington BF, Hagerman RJ. 1998. Phenotypic involvement in females with FMR1 gene mutation. Am J Ment Retard 102(6):590-601.
27. Rousseau F, Heitz D, Biancalana V, Blumenfield S, Kretz C, Boue J, Tommerup TN, van der Hagen C, DeLozier-Blanchet C, Croquette M-F, Gilgenkrantz S, Jalbert P, Voelckel M-A, Oberle I, Mandel J-L. 1991. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. NEJM 325:1673-1681.
28. Rousseau F, Heitz D, Tarleton J, Macpherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddalena A, Spiegel R, Schinzel A, Marcos JAG, Schorderet DF, Schaap T, Maccioni L, Russo S, Jacobs PA, Schwartz C, Mandel J-L. 1994. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB 12.3: The first 2,253 cases. Am J Hum Genet 55:225-237.
29. Rudelli RD, Brown WT, Wisniewski K, Jenkins EC, Laure-Kamionowska M, Connell F, Wisniewski HM. 1985. Adult fragile X syndrome. Clinico-neuropathological findings. Acta Neuropathol 67:289-295.
30. STATA Statistical Software. 1997. Release 5.0, College Station, Stata Corporation, Texas.
31. Tamanini F, Willemsen R, van Unen L, Bontekoe C, Galjaard H, Oostra BA, Hoogeveen AT. 1997. Differential expression of FMR1, FXR1, and FXR2 proteins in human brain and testis. Hum Mol Genet 6:1315-1322.
32. Tanner JM, Hiernaux J, Jarman S. 1969. Growth and physique studies. In: Weiner JS, Lourie JA, editors. Human Biology: A guide to field methods. IBP handbook. Oxford: Blackwell. No 9. pp 1-76.
33. Tassone F, Hagerman RJ, Ikle DN, Dyer PN, Lampe M, Willemsen R, Oostra BA, Taylor AK. 1999. FMRP expression as a potential prognostic indicator in Fragile X syndrome. Am J Med Genet 84:250-261.
34. Tassone F, Hagerman RJ, Taylor AK, Mills JB, Harris SW, Gane LW, Hagerman P. 2000. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 91:144-152.
35. Taylor AK, Safanda MZ, Fall C. 1994. Molecular predictors of involvement of fragile X females. JAMA 271:507-514.
36. Varrela J, Vinkka H, Alvesalo L. 1984. The phenotype of 45,X females: An anthropometric quantification. Ann Hum Biol 11:53-66.
37. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu Y-H, Kuhl DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Omen GJB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation on fragile X syndrome. Cell 65:905-914.
38. Weiler IJ, Greenough WT. 1999. Synaptic synthesis of the Fragile X protein: Possible involvement in synapse maturation and elimination. Am J Med Genet 83:248-522.
39. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, Comery TA, Patel B, Eberwine J, Greenough WT. 1997. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94:5395-5400.
40. Willemsen R, Mohkamsig S, De Vries B, Devys D, Ouweland A. 1995. Rapid antibody test for fragile X syndrome. Lancet 345:1147-1148.
41. Witt RM, Kaspar BK, Brazelton AD, Comery TA, Craig AM, Weiler IJ, Greenough WT. 1995. Developmental localization of fragile X mRNA in rat brain. Society for Neuroscience Abstracts 21:1-(293.6).